Background. The Anaesthetic Conserving Device is a modified heat and
Introduction
protective properties on numerous organs (above all cardioprotective and cerebroprotective). (11, 12) Initial attempts at conserving anaesthetic vapours using an open system involved the development of a reflector that incorporated zeolite crystals.
(13) However, because of the possibility of zeolite inhalation causing pulmonary toxicity (14) , one proposed solution was to use a charcoal filter instead of a zeolite one. (15) The principle of the charcoal filter was further developed, leading to the creation of a device for inhalation sedation AnaConDa TM (Anaesthetic Conserving Device; Sedana Medical, Uppsala, Sweden), which enables sedation and analgesia of patients in ICU with isoflurane and sevoflurane. (16) The Anaesthetic Conserving Device (ACD, AnaConDa TM ) is a modified heat and moisture exchanger, which is inserted between the Y-piece of the breathing circuit and the endotracheal tube (ET-tube) (figure 1) and can be used with any type of ICU ventilator (17,18) without a heated humidifier. The ACD contains active lipophilic carbon fibres, which have the capacity to bind 90% of the expired volatile anaesthetic. These are again released with the following inspiratory cycle. Leakage of the anaesthetic into the environment is thus limited and use of the volatile anaesthetic is also more economical and safer for medical personnel. The lost amount of volatile anaesthetic (10%) is replaced by liquid SIGNA VITAE 2016; 11 (1): anaesthetic, which is uninterruptedly supplied to the equipment by a standard syringe pump and then through a miniature evaporator rod vaporises into the breathing gas with which the patient is ventilated. The following review describes the advantages of inhalation sedation using the ACD in comparison to standard intravenous sedation for patients in ICU and highlights the technical aspects of the functioning of the ACD.
Methods
A literature search was conducted using the electronic databases of PubMed, Sage Journals and the Cumulative Index to Nursing & Allied Health Literature (CINAHL) using the following terms: "anaesthetic conserving device", "volatile anaesthetic reflection filter", "AnaConDa"; independently and in connection with terms "sedation" and "intensive care unit". The extract of hits was limited in the databases by the requirements: scientific journals, peer-reviewed articles and entire text.
Works that presented protocols of research, letters to the editor and works that dealt with the use of the ACD in the operating room were not included. Thirty-seven articles were found corresponding to the aforementioned criteria and 29 were retained. We additionally excluded four review papers. Twenty-five articles that met the criteria were included in our review. Articles selected for this review were published in English before December 31, 2014.
Results
Twenty-five articles were included in our review, nine of which are 11(1): randomised clinical studies (table 1), twelve are prospective observational studies, two case reports and two studies were performed in a laboratory environment (bench study). Most research into the ACD has been done in Sweden (8), France (6) and Germany (5) . The number of patients in clinical studies varied from six to 126 patients.
Inhalation sedation with the ACD in ICU -Clinical trials
The majority of clinical studies evaluated the feasibility of inhalation sedation with the ACD and ascertained its advantages over intravenous forms of sedation. They primarily compared the awakening time of patients after sedation, which was assessed as the time from ending sedation to removal of the ET-tube and the time to an appropriate verbal response of the patient. The quality of sedation and awakening was evaluated by assessment of the depth of sedation, stability of the cardiovascular system of patients, the occurrence of delusions and hallucinations, the occurrence of adverse effects, the length of stay in the ICU and in hospital and an assessment of the costs of sedation and analgesia in the ICU. Table 1 values did not change significantly between the two forms of sedation.
The study only included patients (n=13) with normal (<18 mmHg) and untreated ICP.
Some studies (29, 32, 33) Sturesson et al. (39) argue that use of the ACD increases the apparent dead space to a greater extent than can be explained by its internal SIGNA VITAE 2016; 11 (1): volume. In fact, they demonstrated that the ACD adsorbs exhaled CO 2 , which is returned during the next inhalation cycle, creating an additional apparent dead space. In further studies, the same authors found that the humidity of the gas exhaled by the patient (40) and the presence of volatile anaesthetic in the breathing circuit (41) reduce the rebreathing of CO 2 , although it is still present. A study on patients sedated with sevoflurane using the ACD showed an 88 mL larger apparent dead space than with a conventional heat and moisture exchanger (50 mL due to the larger internal volume of the ACD and 38 mL due to the rebreathing of (41) showed that with use of the ACD, it may be difficult to maintain normocapnia in patients with tidal volume <6 mL/kg, even when the respiratory rate is increased. A recent study by Chabanne et al. (42) showed that use of the ACD in ICU patients worsens ventilatory This aspect of the use of the ACD must therefore be additionally studied.
Discussion
The clinical use of inhalation sedation in ICU was described in the late probably explains the greater capacity of that anaesthetic to produce renal injury from fluoride production. This is in agreement with several studies in which no differences in creatinine levels in the serum of patients who were sedated with sevoflurane, propofol or isoflurane were SIGNA VITAE 2016; 11 (1): reported. (21,29) Despite the large number of studies investigating the use of inhalation sedation with the ACD in adult patients, almost no research has been carried out on the use of inhalation sedation in critically ill children. It is well known that optimal sedation in critically ill children is often difficult to achieve due to the altered pharmacokinetics and dynamics in children.
Tolerance and withdrawal after long-term benzodiazepine use in paediatric ICU has been described. (50) supply line with valve and screw cap, 3 Gas measurement port, 4
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